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RESUMO 
Pacientes com Lesões Vertebro-Medulares (LVM) ainda enfrentam problemas físicos, psicológicos e 
económicos, uma vez que os tratamentos atuais são insatisfatórios no que toca a terapias regenerativas que 
levem a uma recuperação completa e funcional. Várias estratégias têm surgido para o tratamento desta 
patologia, no entanto, terapias individuais mostraram-se insuficientes em reparar com sucesso as LVM. Por 
essa razão, abordagens combinatórias que atuam de forma sinergistica, ajudam a superar este problema, 
uma vez que uma combinação de técnicas melhora ou evita as limitações da utilização de uma técnica 
individual. Assim sendo, neste estudo foi avaliada a eficácia de três hidrogéis naturais: Gellan-Gum 
(funcionalizado com um peptídeo de fibronectina), colágenio e NVR-Gel na promoção de neuritogénese, 
usando um modelo in vitro de crescimento axonal baseado em explantes de Gânglios da Raiz Dorsal (DRGs). 
Em segundo lugar, foi avaliado os efeitos combinados dos hidrogéis com as células mesenquimais do tecido 
adiposo (ASCs), e os efeitos nas propriedades regenerativas do seu secretoma, usando co-culturas de ASCs 
com os explantes de DRGs, sobre os diferentes hidrogéis. Em seguida, foi testada uma abordagem 
biomecular, em que o GDNF (Factor Neurotrófico derivado de Células Gliais) foi covalentemente ligado a 
nanoparticulas (NPs) de óxido de ferro, para determinar o seu efeito no crescimento e comprimento axonal, 
usando o mesmo modelo in vitro. Por último, foi avaliado o uso combinado das NPs com as ASCs nos 
hidrogéis, para avaliar a sustentabilidade desta abordagem de engenharia de tecidos para reparar LVM. Este 
trabalho demonstrou que o uso de hidrogéis auxila o crescimento axonal e a sobrevivência das ASCs, fornece 
uma matriz que é permissiva para o crescimento de novos axónios e aumenta o conhecido potencial 
regenerativo das células estaminais mesenquimais. Os resultados também revelam a importância de ter 
pistas biológicas, tais como moléculas da matriz extracelular, para promover um efeito mais eficaz e 
pronunciado tanto nas culturas de ASCs como nas de DRGs. Além disso, a interação das ASC com o colágenio 
afetou positivamente a viabilidade das ASCs, a sua morfologia e o seu secretoma, além de promover o maior 
crescimento axonal das três matrizes, indicando que esta é uma forte estratégia para aplicações em LVM. 
Em relação à abordagem biomolecular, os resultados demonstraram uma melhoria do GDNF tanto nas NPs 
como na forma solúvel, confirmando os efeitos positivos de utilizar suporte neurotrófico. No entanto, observou-
se que as NPs tiveram efeitos prejudiciais nas ações parácrinas das ASCs, algo que deve ser investigado 
antes da sua utilização combinada. Esta tese estabeleceu que a interação ASC-colágenio é suficiente para 
melhorar significativamente o crescimento axonal, e que às vezes "menos é mais", visto que este último 
grupo induziu uma maior neuritogénese do que a abordagem combinatória com as NPs. Uma compreensão 
mais profunda das diferentes interações pode dar novas perspectivas para abordagens de engenharia de 
tecidos, e talvez ficar um passo mais perto de uma recuperação bem sucedida e funcional das LVM. 
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ABSTRACT 
Patients with Spinal Cord Injury (SCI) still face physical, psychological and economic problems, since current 
treatments are unsatisfactory regarding regenerative therapies that translate into a complete and functional 
recovery. Numerous strategies have been arising for the treatment of this pathology, but single therapy 
approaches demonstrated to be insufficient for the successful repair of SCI. Therefore, combinatorial 
approaches that act in a synergistic arrangement, may help to overcome this problem, as a combination of 
techniques will avoids the limitations of using a single individual technique. Thus, in the present study, it was 
evaluated the efficacy of three natural hydrogels: Gellan-Gum (functionalized with a fibronectin peptide), 
Collagen and NVR-Gel in promoting neuritogenesis, using an in vitro model of axonal regeneration based on 
Dorsal Root Ganglia explants (DRGs). Secondly, it was assessed the effects of combining the three hydrogels 
with Adipose tissue-MSCs (ASCs) and the effects on the regenerative properties of their secretome, using co-
cultures of ASCs with the DRGs explants, on the different hydrogels. Then, a biomolecular approach using 
GDNF (Glial cell-derived Neurotrophic Factor) covalently attached to iron oxide nanoparticles (NPs) was tested, 
to determine their effect on axonal growth and length, using the same in vitro model. Lastly, it was evaluated 
the combined use of the NPs with the ASCs and the hydrogels, to assess the sustainability of this tissue 
engineering approach for SCI. This work demonstrated that the use of hydrogels supports both axonal growth 
and ASCs survival, providing a permissive matrix for the regrowth of new axons and enhances the known 
regenerative potential of the Mesenchymal like Stem Cells isolated from the adipose tissue (ASCs). The results 
also reveal the importance of having biological cues, such as ECM molecules, to promote a more effective 
and pronounce effect on both the ASCs and DRGs cultures. Moreover, the interaction of the ASCs with the 
collagen affected positively the ASCs’ viability, morphology and secretome, besides promoting the highest 
axonal growth of the three matrices, indicating that this is a strong strategy for SCI applications. Concerning 
the biomolecular approach, results demonstrated an improvement by both GDNF-NPs and soluble GDNF, 
confirming the positive effects of using neurotrophic support. However, it was observed that the NPs had a 
deleterious effects on the ASCs paracrine actions, a fact that should be further investigated before their 
combined use. This thesis established that ASCs-Collagen interaction is sufficient to significantly improve the 
axonal growth, and that sometimes “less is more”, as the same group induced a higher neuritogenesis than 
the combinatorial approach with the NPs. A deeper understanding of the different interactions might give new 
insights for tissue engineering approaches, and perhaps getting one step closer to a successful and functional 
recovery from SCI. 
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1.1 The Central Nervous System 
 
The Nervous System consists of two major parts, the Peripheral Nervous System (PNS) and the 
Central Nervous System (CNS). The latter comprises two structures, the brain and the Spinal Cord (SC) 
[1]. The nervous tissue within the CNS is composed of highly specialized and differentiated cells called 
neurons that form an interconnected circuit, able to transmit and receive signals, through complex cell to 
cell interactions. There are several types of neurons, which can be classified according to their function 
(e.g. sensory, motor or interneuron), to the neurotransmitter they synthetize (e.g. glutamatergic, 
cholinergic) and to the shape (e.g. pyramidal, granule). Neurons are composed by the nerve cell body, 
where the large nucleus is surrounded by cytoplasm, and by one or more axons (depending on the type 
of neuron) that transmit the signal to interconnected target neurons. Neurons also have dendrites that 
are responsible for receiving the synaptic contacts from other neurons and are able to branch into 
dendritic spines. The neurons and their extensions possess a large amount of microtubules (elongated 
tubules) that support the elongation of axons and dendrites, besides helping the reciprocal transport of 
vital macromolecules and organelles between the cell body of a neuron and the distant axons/dendrites.  
Neurons communicate between them through chemical actions, in an activity-dependent secretion 
of neurotransmitters that occurs at specialized points of contact, which are called synapses[2]. The 
formation of synapses is essential for the development of functional neuronal networks, allowing neurons 
to communicate and influence other neurons[3]. The CNS also has numerous non-neuronal support cells 
called neuroglia, being the latter divided in macro and microglia. Macroglia are the most abundant support 
cells in the CNS. They can be either astrocytes, which play a supportive role for neurons, helping the 
removal of excessive extracellular neurotransmitter secretion and maintaining the homeostasis; or 
oligodendrocytes, which are a myelin-producing cells. Myelin is made of multiple layers of compacted 
membranes of the oligodendrocytes and has an important role in neurons. Myelin shields the long 
segments of axons, enhancing the conduction velocity of the action potential, in other words, it accelerates 
the synaptic signals making their transmission/reception quicker and more efficient. The other type of 
glia cells, the microglia, are most likely from mesodermal origin, and act as the immune cells of the 
CNS[4]. 
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1.2 Spinal Cord Anatomy 
 
The SC is a cylindrically formed bundle of central nervous tissue[1] that lies within the vertebral 
canal. Unlike the brain, the grey matter of the SC is in the middle and white matter surrounds it. The 
white matter is mainly composed by myelinated axons while the grey matter consists in cell bodies and 
dendrites of efferent neurons, interneurons, glial cells and the entering fibers of afferent neurons. In the 
middle of the grey matter there is an orifice called the central canal, filled with cerebral spinal fluid that 
aids nourishing the nervous tissue. The SC starts in the medulla ablongata (in the base of the brain), 
leaves the skull through the foramen magnum and extends until the firsts lumbar vertabrea[5]. It is divided 
into five regions: 1) the cervical, 2) the thoracic, 3) the lumbar, 4) the sacral and 5) the coccygeal region. 
Each region has a specific number of paired spinal nerves that varies between species. In humans it is 
constituted by 8 cervical pairs, 12 thoracic, 5 lumbar, 5 sacral and 1 coccygeal pair, making a total of 
31 pairs (Figure 1) [6]. Spinal nerves are nerve roots that are bundled together and exit the vertebral 
column through the intervertebral foramina[5]. Each spinal nerve is formed by an anterior root that carries 
motor information (efferent root) and a posterior root, which transports sensory information (afferent root). 
In each posterior root, also termed dorsal root, there is an ovoid structure called the Dorsal Root Ganglion 
(DRG) that contains pseudo-unipolar neurons. These types of neurons possess one single axon that later 
bifurcates into two branches, where one is connecting with the periphery and the other is connecting with 
the dorsal horn of the SC. All these structures allow the SC to assimilate the signals sent by the different 
brain regions and translate them into voluntary movement signals, while receiving the sensory input from 
the PNS and transmitting those signals to the brain. 
The SC is protected not only by the vertebral column, which is composed of individual vertebrae, 
but also by three membranes of connective tissue, termed meninges[1]. The outer membrane protecting 
the spinal cord is called the dura mater, the middle membrane is the arachnoid mater and the inner 
membrane the pia mater. Between the arachnoid and pia mater there is a space called the subarachnoid 
space, which is filled with cerebrospinal fluid. Also, between the dura mater and the periosteum there is 
a space, named the epidural space, which is filled with loose fibrous and adipose connective tissue. The 
existence of these spaces offers extra protection to the SC[5]. This delicate structure functions as a vital 
link between the brain and the PNS by managing the ascending and descending fiber tracts. Moreover, 
it participates in more autonomous functions like most of the viscera and blood vessels of the thorax, 
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abdomen and pelvis[1], setting the rhythmic activity of muscle cells, breathing[7] and producing spinal 
reflexes[5].  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.3 Spinal Cord Injury 
 
Spinal Cord Injury (SCI) is a devastating condition with an annual incidence of 25.5 cases per 
million and is mainly caused by motor-vehicle crashes, sport associated accidents and injuries related to 
violence or falls[8]. The American Spinal Injury Association (ASIA) defines the severity of the lesion through 
the ASIA Impairment Scale (AIS), which is a five-level (A-E) scale that rates the patients accordingly to 
their remaining and/or lost function[9]. Individuals with SCI, experience the breakdown of neuronal 
projections between the brain and the area below the injury, resulting in complete or incomplete 
paraplegia, tetraplegia or quadriplegia (depending on the zone and severity of injury). This injury also 
affects more autonomous functions has respiration, bowel and bladder movement and sexual function, 
impairing the life quality of individuals with SCI[1]. In addition, these patients present a higher risk of 
Figure 1 - Spinal cord sections and their correspondent areas of innervation. Adapted from Purves et al.[1]. 
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pressure ulcers, cardiovascular complications, deep vein thrombosis, osteoporosis, autonomic dysreflexia 
and neuropathic pain[10].  
Due to its important role in several functions, one can envision the physical, psychological and 
economic complications resulting from a sudden or sustained trauma to the SC. This initial trauma is 
known as the “primary injury” and is the starting point for a cascade of biochemical and cellular processes 
called “secondary injury”, which begins in a course of minutes to weeks[5]. As the neurological damage 
continues, a glial scar is formed and the ascending and descending neuronal tracts are interrupted (Figure 
2)[11]. All these events lead to the impairment or loss of neural function [5]. Since this pathology is so 
heterogeneous, in the way that several biological events occur at various levels in a course of minutes to 
years, it is important to further understand the “primary injury”, “secondary phase” and consequently 
the chronic phase[1].  
The primary injury can be triggered by the maceration or laceration of the SC by a penetrating 
force, a vascular insult, or a contusion/compression of the SC by a blunt force or a dislocated bone (being 
this the most common injury)[5]. Upon trauma, the blood flow and the blood-spinal cord barrier are 
disrupted, originating an haemorrhage that progresses to edema, ischemia and necrosis[10]. The 
“secondary injury” is caused by the accumulation of molecules (e.g. glutamate) in the extracellular fluid, 
which causes the hyperactivation of neurotransmitter receptors, leading to increased neuronal cell death 
by excitotoxicity[1]. Also, the swelling and lysis of cells increases the extracellular calcium (Ca2+) levels, 
which triggers the Ca2+ influx into the neurons, activating a Ca2+ dependent neuronal apoptosis that 
accentuates neuronal death[12]. Apoptosis not only affects neurons, but also microglia and 
oligodendrocytes, whose death is known to have a role in the post-injury demyelination. Other ionic 
imbalances, as for example, in potassium (K+) and sodium (Na+) levels result in the depolarization of the 
cell’s membrane. Moreover, the formation of free radicals and lipid peroxidation will impair the function 
of some enzymes (e.g. ATPase) by oxidative stress, leading to loss of neuronal function[5]. 
Simultaneously, an inflammatory response arises by the recruitment of cells from the CNS immune 
system, such as microglia, and non-cellular components like cytokines and chemokines[1]. The activation 
of astrocytes and resident microglia leads to their migration to the injured site so they can begin 
phagocytosing cell debris (e.g. myelin debris) to prevent further damage. Also, leukocytes infiltrate the 
lesion site and release cytokines and reactive oxygen species (ROS) that further damage the neurons and 
demyelinates the surviving ones[5]. At the same time, due the disruption of the blood-spinal cord barrier 
by the trauma, infiltrating peripheral macrophages enter the spinal cord and further aggravate cell death 
and demyelination[13].  
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As the damage progresses throughout days or weeks, a fluid-filled cavity is formed in the injured 
site[9] and a dense network of fibrous astrocytes surrounds it, creating a glial scar. Even though this scar 
function is to constrain the injury and avoid its spreading to surrounding tissue, it also works as physical 
barrier for axonal growth[13] by hindering their reconnection across the scar. Furthermore, the reactive 
astrocytes within the scar secrete inhibitory proteins (e.g. chondroitin sulphate proteoglycans)[9] and 
axonal growth inhibitor/repulsive proteins (e.g. myelin-associated proteins) that also form a chemical 
barrier for regeneration. The local inhibitory environment along with the lack of growth promoting factors 
(e.g. axon-growth promoting factors and/or extracellular matrix proteins), as well as the overall complexity 
of this pathology, hinders a complete and functional recovery[14]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 2 - Representation of a spinal cord injury, with the respective pathophysiological events that occur 
post-injury. Image adapted from Mothe et al.[2]. 
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1.4 Current Treatments 
 
The adult CNS has a limited capability for regeneration and the current treatments for SCI offer 
insufficient regenerative strategies, being the treatment mostly palliative. One of possible routes is to 
surgically decompress and stabilize the SC. However, the heterogeneity of the SCI and the individuality 
of each patients hampers a clear assessment of which patients would benefit from those procedures and 
which is the optimal timing for such interventions to occur[5]. Likewise, several pharmacological 
approaches have been tested, such as opiate receptor antagonists (naloxone), potassium channel blocker 
4-aminopyridine (fampridine) and steroids (tirilazard and methylprednisolone). However, 
methylprednisolone (MP)[15] (a corticosteroid that inhibits lipid peroxidation by scavenging free 
radicals[5]), was the only to provide significant improvements in sensory and motor function in animal 
studies and motor function in human patients with SCI [15]. Even though this is the most prescribed drug 
for SCI related interventions, its use is still controversial due to the need of high doses to produce a 
neuroprotective effect and the severe side effects derived from its use, which can aggravate the patient’s 
state. In addition, in this treatment is also unclear in which patients its use is more effective and in which 
phase would it be used [5]. So, in 2002 the American Association of Neurological Surgeons and the 
Congress Neurological Surgeons (AANS/CNS) recommended that MP treatment should only be 
administrated with the patients notion that the evidence suggesting potential harmful side effects is more 
consistent than any suggestion of clinical benefits[9]. Lastly, symptomatic therapy is applied, that is the 
control and management of the pain, the infections (e.g. urinary, skin) and the bladder, bowel and 
reproductive functions to minimize the patients’ discomfort. Along with this, patients go through 
rehabilitation to train the reflexes and residual circuits to improve their life quality[15].  
In order to repair the injured spinal cord, several steps need to be achieved, such as decreasing 
the progressive cell death and glial scar formation while replacing the lost cells by the production of new 
cells and the protection of the surviving ones. Also, there is the need to reconnect the spared nerve fibers 
with their original (or substitute) targets through the maximization of its functions and the repair of their 
lost myelin sheaths. Since no current treatment offers an approach to tackle the heterogeneity of the SCI, 
laboratories all around the world are developing several approaches to address the different events 
occurring in the SCI, which will be discussed on the following topics[16].  
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1.5 Therapeutic Strategies for SCI Repair  
1.5.1 Biomaterials 
 
Unlike the PNS, the axons from the adult CNS have a very low ability to spontaneously regenerate 
after a trauma, mainly due to the formation of a glial scar and the existence of a growth inhibitory 
environment[17]. In recent years regenerative approaches to treat SCI have been emerging, with 
strategies focused on using smart biomaterials that best suit the challenges offered by the pathology in 
question[9].  
The envisioned function of a scaffold is to provide a cellular microenvironment suitable for cell 
survival and tissue formation, to be biocompatible and biodegrable as newly formed tissue replaces it[18]. 
Among the existing biomaterials, hydrogels are of special interest for SCI due to their physical properties 
that resemble the soft tissues of the CNS[9] and also their porous structure, which allows the diffusion of 
molecules[19]. Hydrogels are polymers that typically have a soft and elastic consistency, owed to their 
high water content, and can be tailored as temporary scaffolds with the desired physical, mechanical and 
chemical properties. Additionally, they can provide a three-dimensional (3D) environment for cells to 
grow[19]. This provides a better mimicking of the human body since in most native tissues, cells are 
arranged in a 3D microenvironment provided by the structurally complex network of the ECM. The ECM 
3D environment allows cellular communication and metabolism, the transport of nutrients and the 
removal of waste while controlling cell growth, organization and orientation[20]. In the case of SCI, 
hydrogels can be implanted at the lesion epicentre, to achieve the bridging of the rostral and caudal parts 
of the injured spinal cord acting as a substrate for axonal growth, support and guidance[21]. These 
biomaterials can be either synthetic such as poly(caprolactone) (PLC)[22], poly(lactic-co-glycolic acid) 
(PLGA)[23],  polyethylene glycol (PEG)[24], poly(lactic acid) (PLA)[25], among others; or from natural 
origin such collagen[26], Gellan-Gum (GG)[27], laminin and hyaluronic acid (NVR-Gel)[28], agarose[29] 
and others. Scaffolds should have a number of properties essentials for promoting a successful 
regeneration, such as[30]:  a) the capability of maintaining their function after in vivo delivery, b) to provide 
an adequate matrix for cell adhesion and proliferation, c) to be biocompatible, d) to influence cells 
behaviour via mechanical or chemical interaction and e) capability of in vivo degradation. These scaffolds 
are normally used to assist cell survival, proliferation and differentiation, however by altering certain 
aspects of the hydrogel it is possible to use them to influence cells’ behaviour. It is hypothesized that the 
 8 
 
closer the scaffold mimics the natural ECM, the more efficient will be its effect on providing a more 
conductive and permissive environment for the adhesion, migration and proliferation of cells[20]. Initially 
ECM was thought to function only has a 3D matrix for cells’ mechanical support, but now it is known to 
have more important functions. The ECM has various tissue-type dependent fibrous proteins, 
proteoglycans and matricellular proteins. Also, the structural fibril proteins of the ECM such as fibronectin, 
collagen and laminin have several binding sites for proteases, growth factors and engage cell-surface 
integrins. Integrins are heterodimeric cell surface receptors that assist cell to cell and cell to ECM 
interactions. Therefore, ECM besides giving structural support it also functions as a reservoir for cellular 
signalling molecules[17]. Furthermore, it is known that many physicochemical properties of the natural 
ECM can influence the surrounding cells’ biological cues. For example, the basal membrane of several 
tissues exhibits a vast nanotopography that affects cell behaviour such as adhesion, organization and 
migration. Other ECM molecules like collagen or hydroxyapatite crystals have nanostructures that are 
believed to contribute to cell matrix signalling[20]. Indeed, several studies indicate that physical 
entrapment of adhesive motifs into the biomaterial can influence and enhance the survival, proliferation 
and fate of several cell types[17]. Having this in mind, when designing a scaffold for a soft tissue as the 
SC, some aspects such as stiffness of the hydrogel, its efficient integration in the damaged tissue and 
their ligand density for integrin binding should be considered for a more effective end result[31].  
 
1.5.1.1 Synthetic hydrogels 
The bigger advantage of synthetic hydrogels is the possibility of being tailored in terms of 
composition and design, biocompatibility, mechanical and chemical properties and rate of degradation 
to serve the needs of the pathology. Moreover, the use of a biocompatible but completely artificial material 
reduces the allergenic risk due to the inexistence of animal proteins[18] and allows an easier large-scale 
production[18]. Another example of combination of polymers to best serve certain proposes is the 
Poly(D,L-lactic acid co-glycolic acid) (PLGA), which is an amorphous copolymer formed by the 
polymerisation of poly(glycolic acid) (PGA) and PLA. This polymer lacks a definite repeating form, shape 
or structure, which originates a less rigid, weaker and more easily deformed polymer. This allows the 
control of its mechanical properties and rate of degradation by adjusting the ratio of PGA/PLA[30]. This 
polymer is biocompatible and was FDA approved for human peripheral nerves repair, which makes it a 
promising biomaterial for SCI[9]. One study tested the ability of a PLGA surface to maintain the viability, 
proliferation and the typical morphology of Mesenchymal Stem Cells (MSCs) with their intended delivery 
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into injured SCs. Indeed, the results showed that PLGA was a suitable scaffold for the delivery of MSCs 
as it maintained their survival, proliferation and morphology. Moreover it did not change the beneficial 
secretory activity of neuroregulatory molecules, which are the base for the therapeutic efficacy of these 
cells[33].  Also, neural cells seeded on PLGA scaffolds were able to survive and migrate out of the scaffold 
to innervate host tissue, while host cells and processes were innervating the scaffold[34]. Finally a 
biocompatible hydrogel of poly[N-(2-hydroxypropyl) methacrylamide] (PHPMA) with viscoelastic 
properties and porous structure, for neural tissue repair, has also been used. The hydrogel was applied 
in a transected rat SC, to assess its capability of promoting tissue repair and axonal regeneration. They 
demonstrated that the hydrogel bridged correctly the tissue defect by acting as a permissive substrate to 
host tissue and cells, allowing their ingrowth. Histological analysis demonstrated that 3 months post-
implantation the PHPMA hydrogel had been infiltrated by host glial cells, blood vessels and growing axons, 
which lead to an improvement in the locomotor function of some animals after SCI[35]. Further studies 
using the same hydrogel were made to evaluate its incorporation in the injured SC, its ability to promote 
reparative tissue formation and bridge the tissue defects on a double-transection lesion to the SC of rats. 
This study confirmed that the hydrogel had successfully incorporated the lesion site, bridging the tissue 
defects and allowing the integration of host cells, re-growing axons and blood vessels. These outcomes 
were related with the hydrogel’s mechanical properties that promoted the integration into the host tissue 
and its macromolecular network that allowed molecule diffusion and host cells integration, survival and 
proliferation[36]. 
 
1.5.1.2 Natural Hydrogels 
A crucial aspect to consider when developing a hydrogel is its integration on the lesion site and 
the interaction with the host tissue and cells. The ECM of the CNS is composed of proteoglycans like 
chondroitin sulfate proteoglycans (CSPGs), glycosaminoglycans as hyaluronan (HA) and proteins such as 
fibronectin, laminin and collagen[14]. However, CNS ECM lacks fibrillar collagens and fibronectin when 
compared with the systemic tissues, being rich in glycoproteins and proteoglycans[37].  
The closest a scaffold resembles the complex network of the native tissue in which it will to be 
applied, the bigger influence it will have. This lead researchers to study the synthesis of hydrogels with 
molecules naturally present in living tissues[17]. Hydrogels from natural origin provide polymers that are 
exceptionally similar to living tissues, allowing therefore the stimulation of a specific response that is very 
difficult to mimic with synthetic hydrogels. Moreover, due to their similarity with the natural ECM, natural 
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polymers provide a low immunological response. Additionally, they tend to induce a decreased 
inflammatory response and toxicity in comparison with synthetic polymers[18]. For neural tissue repair 
these hydrogels are appealing since they provide substances present in the ECM or have certain 
properties that are recognized by cells, which allows the hydrogel’s integration within the host[9].  
 
For example Collagen hydrogels are widely used for research purposes since it has been 
reported to be the main constituent of almost all ECMs[38]. Hydrogels made of collagen can be easily 
manipulated while still maintaining the same concentration, pH and density[39]. Additionally, collagen 
has low antigenicity with outstanding biocompatibility and presents a good biodegradability in vivo[26]. In 
vitro studies showed its capacity to form adhesive subtracts that are permissive to neurite outgrowth[37] 
and also promotes a significant improvement in cell adhesion and neuron survival[40]. In one study, 
Neural Stem/Progenitor Cells (NSPCs) dispersed on a type I collagen hydrogel were able to actively 
expand within the gel and to efficiently generate neurons that had developed neuronal polarity, 
neurotransmitter and excitability. These results show that this 3D matrix was able to support the 
development of functional synapses and the formation of a neuronal network[3].  
Other type of natural hydrogel is Gellan-Gum (GG), which is a linear anionic polysaccharide 
that is produced by the bacterium Pseudomonas elodea. It exists in the acetylated and deacetylated form, 
resulting in a thermoreversible gel that changes its mechanical properties according to the degree of 
deacetylation. This hydrogel presents no toxicity and its gelation process is ionotropic, that is, for the 
formation of a stable structure within the hydrogel the presence of cations is needed[9]. Even though GG 
(as others ionic-crosslinked hydrogels) suffers a significant dissolution in vivo, which compromises its 
structural integrity, it possesses a free carboxylic group per repeating units that can be used for 
functionalization and to enhance its bio-stability[41].  
Silva et al. [42] originally puporse the use of GG for SCI applications. In this study oligodendrocyte 
like cells were shown to be viable when encapsulated in the GG hydrogel structure. Moreover when 
injected, in a hemisection SCI rat model, showed to be noncytotoxic, biocompatible, did not trigger a 
chronic inflammatory response and was well integrated within the lesion site. This work was then further 
improved by the same team by modifying the GG with a fibronectin derived peptide (GRGDS). This 
approach lead to greater cell adhesion and viability of NSPCs in comparison with the unmodified GG[27]. 
The use of fibronectin can be advantageous because of its ability to bind to the cell’s integrins receptors 
to promote cell adhesion and viability[14]. Moreover, this fibronectin peptide has the Arg-Gly-Asp (RGD) 
site that is a frequently used peptide ligand for many integrins[43].  
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Another natural hydrogel is the NVR-Gel that is composed of high molecular weight (3x106 Da) 
hyaluronic acid (HA) and the adhesive molecule laminin. This gel is transparent with a viscous liquid 
texture and is highly hydrated with polar and non-polar (hydrophobic) residues, all of which are 
biocompatible and biodegradable[28]. HA is an anionic, nonsulphated glycosaminoglycan and a long 
linear polysaccharide composed of repeating nonsulphated N-acetyl-glucosamine and glucuronic acid 
disaccharide units[44]. HA has the high and low molecular weight form that have different charge and 
hydration properties, which influences the hydrogel biological properties as for example the viscosity and 
interactions. In the ECM, HA provides a matrix architecture to which proteoglycan and glycoproteins are 
non-covalently recruited. It also plays a vital role in cell morphogenesis and proliferation due to its 
biophysical properties (by contributing to the ECM structural integrity) and its cell-surface HA receptor 
interactions, which can be advantageous for the combination of cells, for example[37]. The use of laminin 
is also interesting since recent observations of neurogenic niches of the adult CNS showed the presence 
of laminin protein in their extracellular matrix[45]. Laminins are heterotrimeric glycoproteins molecules 
that form the main noncollagenous glycoprotein of the basal lamina. Laminins are adhesive and growth 
promoting molecules that form a substrate for neuronal migration and axonal pathfinding in 
development[37]. Indeed, NSPCs from human embryonic stem cells, postnatal human cells and mouse 
embryonic cells were cultured in adherent subtracts coated with laminin and were able to adhere, survive 
and differentiate into neurons[17]. Long-term experiences using NVR-Gel have shown that it successfully 
adheres dorsal root ganglia (DRG) and spinal cord (SC) slices to the substrates providing an excellent 3D 
milieu for the growth of neuronal tissue in culture. The same group applied the NVR-Gel, combined with 
growth factors, on chitosan structures and demonstrated sprouting of neuronal fibers and cell migration 
from the DRGs slices and the onset of myelin in DRG organotypic cultures[28]. NVR-Gel also seems a 
good approach for SCI as it promotes neurite outgrowth, supports cell maturation and nerve fiber 
outgrowth with the advantage of having adhesive properties that allows also the combination of growth 
factors or cells[46].  
 
 
 
 
  
 12 
 
1.5.2 Mesenchymal Stem Cell-based therapies 
Mesenchymal Stem Cells (MSCs) are non-hematopoietic multipotent stem cells of mesodermal 
origin that initially were isolated from bone marrow[17]. However, new sources of MSCs have been 
discovered recently, such as the periosteum, muscle, adipose tissue, deciduous teeth, articular 
cartilage[47] and the Wharton Jelly of the umbilical cord[48]. These cells present a characteristic spindle-
like morphology and have the capacity to self-renewal and differentiate into the several cell types from 
the three embryonic germ layers, such as adipocytes, osteoblast, myoblast, skin and chondrocytes[17]. 
Moreover, MSCs have the capacity to migrate and exhibit site-dependent differentiation has a response 
to environmental signals. This is advantageous since upon lesion they migrate to the injured site in 
response to intrinsic signals, and may rescue the surviving cells and accelerate regeneration[49]. 
According to the International Society for Cell Therapy (ISCT) some minimal criteria for identifying cells 
as MSCs are: I) adherence to plastic under standard culture conditions; II) positive expression of specific 
markers, namely CD73, CD90, and CD105; III) negative expression of hematopoietic markers, specifically 
CD34, CD45, CD14 or CD11B and CD79a or CD19; and IV) at least the differentiation into than 
adipocytes, chondroblasts and osteoblasts, in vitro. MSCs have a widespread distributions throughout the 
body, which makes them advantageous for cell-focused therapies, along with the fact of being easy to 
isolate and expand (no technical or ethical problems)[50]. Moreover, these cells have a great proliferation 
potential upon isolation, show minimal senescence through multiple passages[48] and can be used for 
autologous approaches with no risk of tumor formation[50]. In recent years these cells have been 
appealing for CNS-related disorder because they offer low immunogenicity, immunomodulatory, 
neuroprotective and anti-inflammatory character with pro-survival and differentiation properties[51]. 
These effects are now known to be related with the paracrine actions of their secretome, that is, the 
growth factors, micro-vesicles and exosomes that they secrete to the extracellular milieu[50]. Although a 
full characterization of the secretome is still lacking, some groups have identified some molecules such 
as: Insulin-like Growth Factor (IGF); Vascular Endothelial growth Factor (VEGF); Brain-Derived 
Neurotrophic Factor (BDNF); Fibroblast growth factor-2 (FGF-2)[52]; Neurotrophin-3 (NT-3); Nerve Growth 
Factor (NGF), among others[48]. However, the expression of these factors varies among the existent 
MSCs types. Ribeiro et al. collected the conditioned media (media containing the secreted molecules) of 
MSCs from the adipose tissue (ASCs) and the Wharton Jelly (HUCPVCs) to assess if they had similar or 
opposite effects on primary cultures of hippocampal neurons. The results showed that ASCs conditioned 
media (CM), unlike the HUCPVCs CM, needed some supplementation to provide a significant increase in 
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cell density and metabolic activity. A screening for the presence of the certain factors revealed that ASCs 
CM contained NGF, Stem Cell Factor (STF), Hepatocyte Growth Factor (HGF) and VEGF, while in the 
HUCPVCs CM it was only detectable a robust NGF expression[53]. Numerous studies have proven that 
MSCs secretome is linked to their immunosuppressive character, but also that this ability to secrete a 
wide range of molecules, such as NGF, VEGF or BDNF promotes neurite outgrowth, axonal regeneration 
and glial scar reduction[48]. Concerning the use of cells, the main focus of this thesis is centred on 
Adipose-tissue derived MSCs, for that reason the next chapter will focus specifically on the use of these 
cells.  
 
1.5.2.1 Adipose-tissue derived MSCs (ASCs) 
The adipose tissue is a highly complex tissue that consists of mature adipocytes and a stromal 
vascular fraction (SVF), which contains preadipocytes, fibroblasts, endothelial cells, vascular smooth 
muscle cells, monocytes, lymphocytes and ASCs. This is a promising source for MSCs-based therapies 
since the adipose tissue is abundant, ASC are easily obtained in high quantities and can by harvested 
through lipoplasty or liposuction, providing a low donor site morbidity or patient discomfort[54]. 
Furthermore, ASCs have a greater isolation yield in comparison with other MSCs, as for example, BM-
MSCs (Bone-Marrow MSCs) or HUCPVCs and have a higher proliferation capacity when compared to BM-
MSCs, with a similar senescence time[55]. Furthermore, one study proved that ASCs exhibit in vitro 
immunosuppressive properties similar to BM-MSCs[56]. A study used ASCs in an ischemia/reperfusion 
rabbit model for up to 3 weeks after the injury to check if the neuroprotective effects of the ASCs were 
present for longer periods. ASCs transplantation produced a significant reduction of the reactive microglia 
in the injured site, an increase in the number of surviving neurons and the BDNF expression was 
maintained in the SC during the 3 weeks[57]. Also, ASCs have been shown to secrete prostaglandin E2 
and Interleukin-10 (IL-10), which can be related to their immunosuppressive character, and VEGF, 
transforming growth factor Κ (TGF-Κ) and HGF that help angiogenesis and wound healing[58]. One study 
using human ASCs on a rat model of compression SCI demonstrated their ability to promote axonal 
regeneration, tissue preservation and a functional recovery of the animals, without an immune 
reaction[45]. Moreover, Zhou and co-workers investigated if ASCs transplantation would provide similar 
or better results than BM-MSCs transplantation, using a rat model of SCI. Both types of cells migrated to 
the lesion site without differentiating into neuronal or glial elements, however ASCs transplantation 
resulted in a noticeable change in the SCI environment. These changes consisted in an increase in 
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angiogenesis and the number of preserved axons, reduced the number of activated macrophages and 
inhibited inflammation infiltration. These results were associated to a bigger proliferative activity of ASCs, 
which resulted in a higher expression of HGF, VEGF and BDNF that enhanced the functional outcome 
after SCI in comparison with BM-MSCs. All of these factors show that ASCs might be an encouraging 
approach to tackle the heterogeneity of SCI[59]. Even though these results are promising, ASCs 
transplantation remains a challenge for clinical applications because of some limitations that are 
generalized to most cell-based therapies. The inhibitory environment of the injured SC results in poor 
engraftment and survival of the cells, which hampers this strategy since the incorporation and proliferation 
of the cells into the host tissue is essential[60]. 
 
 
 
 
1.5.3 Biomolecular Approaches for SCI 
 
As previously stated, the reasons for the failure of spontaneous regeneration after SCI are related 
to[61]: a) the presence of chondroitin-sulphate-proteoglycans-related scar tissue that acts as physical and 
chemical barrier for regrowing axons to pass; b) presence of axon-growth inhibitory molecules, such as 
myelin-associated glycoproteins (MAG) or Nogo-A; c) the low intrinsic capacity or potential of the injured 
adult neurons to regrow their axons and d) a restricted supply of appropriated trophic factors and their 
associated receptors. Concerning the latter two reasons, researchers have focused in the administration 
of several neurotrophic factors to stimulate endogenous repair mechanisms, promote neuronal viability, 
neurite outgrowth/axonal regeneration and control the inflammatory/immune response[61]. NGF was 
the first neurotrophic factor to be discovered and once its effects on neurons were demonstrated, many 
others and their important roles have been identified in the CNS during development, adult-hood and in 
injury scenarios[62]. Some of the neurotrophic factors that have been used for SCI repair are NGF, BDNF, 
Glial cell-Derived Neurotrophic Factor (GDNF) and NT-3, among others. BDNF, NGF and NT-3 are part of 
the neurotrophins family, which play a critical role in cell survival, differentiation and axonal growth[63]. 
NGF is known promote long-distance regeneration of primary sensory neurons and studies showed its 
ability to support the survival of sympathetic and sensory neurons in culture[61]. BDNF is the most 
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studied in SCI context due to its ability to induce neurogenesis, neuroprotection, axonal sprouting and 
myelination[63]. Regarding NT-3, this protein is also extensively used for SCI and has been shown to 
enhance neuronal survival axonal regeneration/neurite outgrowth and functional recovery after SCI but 
only on certain neuronal populations[61]. GDNF is another protein that has been proven to enhance the 
survival and outgrowth of both sensory and motor neurons and to stimulate in vivo myelination of 
unmyelinated nerve fibers[46]. Moreover, it reduces the volume of the lesion by decreasing the astrocytic 
reactivity around the lesion site, promotes greater axon sparing and decreases the macrophage 
infiltration[63]. However, the therapeutic delivery of these factors is hampered by their low permeability 
through the blood-spinal cord barrier. The delivery in form of single injection intrathecally or trough mini-
pumps were tested, but problems such as pump blockage/infection, unequal and/or rapid distribution 
and elimination of the growth factors by the cerebrospinal fluid made these approaches insufficient[14]. 
Even if it was able to successfully distribute them on the lesion site, these proteins have a short in vivo 
half-life time resulting from a rapid enzymatic degradation, which leads to the loss of their biological 
activity after short periods of time[46]. In order to overcome these limitations other routes of 
administration have been fabricated, to achieve a localized and sustained release of the neurotrophic 
factors without the need of invasive methods (mini-pumps) or numerous injections of fresh neurotrophic 
factors[23]. 
 
1.5.3.1 Drug Delivery Systems 
Due to recent focus on hydrogels for many functions, one study used a gel to deliver NT-3 into a 
hemisection rat model of SCI to improve the rats’ function. The hydrogel was able to sustained the NT-3 
release during 2 weeks (avoiding multiple injections), which resulted in greater axon growth of motor 
neurons and a functional recovery of the animals in comparison with the controls (hydrogel without NT-
3)[64]. An agarose hydrogel that had embedded microtubules loaded with BDNF was tested for BDNF 
delivery in a hemisection rat model. It demonstrated to be a suitable delivery system since it caused the 
reduction of reactive astrocytes and the production of CSPG besides stimulating the regenerating fibers 
to enter the permissive scaffold[65].  
Likewise, recent advancements in the nanotechnology field have shown their diversity in 
biomedical applications[66]. Among the existing nanomaterials, nanoparticles (NPs), which are already 
used for cell-tracking and as contrast agents for imaging, show promising characteristics for molecule 
delivery systems[67]. Magnetic NPs (NPs) are biocompatible, biodegradable, and non-cytotoxic, provide 
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magnetic properties and offer a high surface-area-to-volume ratio that allows an easier incorporation of 
the factors[46]. One study tested the ability of BDNF-NPs to cross the Brain Blood Barrier (BBB), using 
an in vitro model of BBB. They showed that the BDNF-NPs were non-toxic, passed the BBB and preserved 
the BDNF bioactivity[68]. Polat and co-workers did a comparative study between ΚNGF, GDNF and FGF-
2 action in their soluble form versus their actions once incorporated on NPs. They showed that the NPs 
on the first days of culture already showed an enhancement in the early nerve fiber formation on 
organotypic DRGs cultures in comparison to soluble factors. Moreover, these NPs increased the stability 
of all of the factors for longer periods of time but the GDNF-NPs had the more significant effect by 
accelerating the onset of myelin and effectively progressing the myelination process[46]. All of these 
strategies mentioned in this work have encouraging characteristics for SCI repair, however, their solo 
application is not sufficient to tackle the distinct challenges that SCI offers. For that reason, the combined 
use of the mentioned strategies might takes us a step further to overcome the heterogeneity of this 
pathology. 
 
 
 
 
1.5.4 Synergistic Approaches  
 
Tissue engineering and regenerative medicine approaches offer a new window of possibilities for 
the structural and functional restoration of the damaged or lost tissue and involves the use of biomaterials, 
cells and often growth factors to serve that purpose[69]. This field merges medicine and bioengineering 
with special focus in inducing the formation of new functional tissues instead of implanting spare 
parts[48]. Indeed, along this report it was clear that synergic approaches might address the drawback of 
single strategy approach (Figure 3)[17]. The CNS as low self-repair ability after an injury because mature 
neurons are unable to regenerate themselves and the harsh environment produced on the lesion site 
hampers the ability of any remaining neurons to successfully regrow[70].  
As it was mentioned, MSCs-based therapies for SCI are encouraging but still have the problem 
of poor engraftment and survival and difficulty in maintaining them on the lesion site. However, by using 
biomaterials, such as hydrogels, as a scaffold for MSCs transplant might overcome this limitation. Besides 
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giving support to host axons and cells, hydrogels provide an appropriate 3D microenvironment that 
promotes transplanted cells engraftment, survival, proliferation and integration into the host tissue[71]. 
As previously stated, the use of natural hydrogels provides characteristics that are difficult for synthetic 
hydrogels to mimic and allows the encapsulation of cells, which makes them a good strategy for SCI [17]. 
Moreover, the functionalization with ECM peptides can further enhance their effects besides facilitating 
the integration of both transplanted and host cells[19]. By encapsulating MSCs into 3D hydrogels it is 
possible to locally sustain the cells and promote their survival, which consequently results in a continuous 
production of secretome and its regenerative effects, since the porous structure of the hydrogels allows 
molecule diffusion[72]. One study was performed using a poly N -(2-hydroxypropyl)-methacrylamide 
(PHPMA) hydrogel, functionalized with an RGD sequence, in combination with MSCs to test if this 
approach could result in a functional improvement of the animals. Hejcl et al. tested whether the hydrogel 
could bridge the SC and support the MSCs, and if the MSCs combination enhanced the motor and sensory 
function regarding the hydrogel’s single effect. In this study the injury was caused by a balloon-induced 
compression model and the hydrogels were implanted 5 weeks post injury in order to evaluate the effects 
of this cell-polymer construct on the chronic phase of SCI. The behavioural results demonstrated that 
animals only with hydrogel had a tendency to improve, but the combined treatment (hydrogel and MSC) 
induced a significant improvement in motor and sensory function of the animals. The histological analysis 
revealed that both groups of hydrogels had infiltrating axons, myelinated with Schwann cells, but only the 
combined group had blood vessels and astrocytes infiltration and was able to prevent tissue atrophy. 
These improvements could be related with the trophic support provided by the MSCs transplantation, 
which translated in a greater improvement of both sensory and motor function[73].  
Another aspect to take into account is that after SCI the neurons have a low endogenous ability 
for regeneration. However, extra support can be given through the introduction of exogenous neurotrophic 
factors. The use GDNF is proven to have beneficial effect in both axonal sprouting and myelination 
processes, but its soluble form has a short half-life time in vivo, resulting in the loss of its biological activity 
after short periods of time. Therefore, the use of NPs can stabilize this factor for longer periods of time, 
enhancing its bioactivity and successfully improving their effects without the need of several 
administrations to produce the same effect[46]. 
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Figure 3 - Schematic representation of the reciprocal molecular interactions between the transplanted and host cells, their 
interactions with the extracellular matrix components (biomaterial) and with the exogenous soluble factors. Adapted from 
Phadke et al.[4]. 
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OBJECTIVES 
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2.1 – Synergistic approaches for SCI repair: The combined use of MSC, 
hydrogels and GDNF-NPs 
 
Herein, it is intended to evaluate the efficacy of three natural hydrogels: GG (functionalized with a 
fibronectin peptide), Collagen and NVR-Gel in promoting axonal support and regeneration, using DRG 
explants cultures. Secondly, it will be evaluated the Collagen, NVR-Gel and GG influence on the ASCs 
viability, metabolic activity and gene expression, by seeding the MSCs, more specifically ASCs, on the 
three hydrogels. Then, it will assessed if the combined use of these hydrogels with the ASCs will enhance 
the regenerative properties of the MSCs secretome, using the DRGs explants as the in vitro model. Lastly, 
the addition of a biomolecular approach was tested, where the solo use of GDNF covalently attached to 
iron oxide NPs will be evaluated, with the final purpose of combining the NPs with the ASCs and the 
hydrogels, to assess the sustainability of this tissue engineering approach for SCI. 
 
 
Objective 1 – Determine if the three hydrogels (GG-GRGDS, NVR-Gel and Collagen) are able to 
promote neuritogenesis, by culturing the DRGs explants on the three hydrogels.  
 
Objective 2 – Assess the influence of the three hydrogels on the ASCs survival, metabolic activity and 
gene expression, by encapsulating the cells on the different matrices.   
 
Objective 3 – Evaluate the regenerative ability of the ASCs combined with the hydrogels, on axonal 
growth, by co-culturing the ASCs on the different hydrogels, with the DRG explants.  
 
Objective 4 – Evaluate the biomolecular approach effect on axonal growth and length, using DRGs 
explants. Lastly, evaluate the effect of combining all the components (ASCs, hydrogels and NPs) on axonal 
growth, using the same in vitro model.  
  
 22 
 
  
 23 
 
CHAPTER 3: 
MATERIAL AND 
METHODS 
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3.1 Adipose tissue-derived Mesenchymal Stem Cells (ASCs) culture 
 
The Human ASCs were kindly provided by professor Jeffrey Gimble and isolated according to the protocol 
described by Dubois et al.[74] The stem cells were thawed and cultured in α-MEM (GIBCO, USA), 
previously supplemented with sodium bicarbonate (NAHCO3, MERCK, USA), 10% of Fetal Bovine Serum-
FBS (INVITROGEN, USA) and 1% of penicillin-streptomycin antibiotic (GIBCO). The medium renewal was 
made each 2/3 days and upon confluence the cells were trypsinized, plated into a new T75 flask (NALGE 
NUNC, ROCHESTER, NY), at a density of 4.000 cells/cm2, and incubated at 37ºC in a 5% humidified CO2 
atmosphere. 
 
3.2 Hydrogels Preparation 
3.2.1 Gellan-gum (GG): 
The regular GG (Sigma, USA) was functionalized using a fibronectin-derived peptide (GRGDS). Briefly, the 
gellan-gum was dissolved in MES buffer (100 mM, pH 5.5) and stirred for 48h at 37 oC. Then, the solution 
was dialysed alternately with distilled water and PBS (0.1 M, pH 7.2) for the period of 5 days, and after 
that period the water was removed (through lyophilisation), originating a white powder of furan-modified 
gellan gum (furan-GG). Then, the GRGDS peptide was modified with a maleimide group (mal-GRGDS) and 
through Diels-Alder chemistry, the mal-GRGDS peptide (AnaSpec, USA) was immobilized into the furan-
GG, which originates the GG-GRGDS. First the furan-modified gellan gum was dissolved in MES buffer 
(100 mM, pH 5.5) at 37 oC (10mg/ml), then it was added the mal-GRGDS using a proportion of 5:1 molar 
ratio (maleimide:furan) and stirred at 37 oC for 48h. The mixture was dialysed alternately with distilled 
water and PBS (0.1 M, pH 7.2) for 5 days. After removing the water through lyophilisation it is obtained 
a white powder of GRGDS-modified GG (GG-GRGDS) that will be combined with the regular GG, in a 50:50 
proportion. The both types of GG were dissolved in ultra-pure water (0,5% w/v) and the modified GG was 
sterilized by UV light for 15 min and placed to stir at 40 oC overnight, while the unmodified GG is placed 
at 90ºC for 30min and filtrated before the procedure. After mixing both of the GGs in a 50:50 proportion, 
it is added calcium chloride (CaCl2) in a proportion of 1:10, to start the gelification process.  
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3.2.2 NVR-Gel  
NVR-Gel (NVR Labs proprietary [32]) is mainly composed of two components: high molecular hyaluronic 
acid (HA, 3x106 Da) and laminin. To prepare this hydrogel, a previously made mixture of HA 1% (BTG 
Polymers, Israel) and Laminin (Sigma) was diluted to the concentration of 0,3% in culture medium. The 
solution was then mixed until it was obtained a uniform gel with a liquid viscous texture. After that the 
hydrogel was plated on 24-well plate, where each well contained 250µl of NVR-Gel. For the DRG cultures 
it was used Neuron-Medium (N-M), which is neurobasal serum free medium supplemented with B27, L-
glutamine, glucose and Pen-strep, and for the ASCs monocultures it was used α-MEM. 
3.2.3 Collagen  
The technique and the collagen formula were performed as described by Allodi et al.[39], but some 
alterations were made. The collagen gels were prepared using the proportion of 450 μl of Collagen type 
I (BD Biosciences), 50 μl of Dulbecco’s Modified Eagle Medium 10x (DMEM 10x) (Sigma) and 2 μl of 
7.5% NaHCO3 solution, which were thoroughly mixed to obtain a homogenous gel. Then, drops of 50 μl 
of the hydrogel were placed in each well/coverglass chamber and kept in the incubator for 2h at 37 °C 
and 5% CO2 for the gelification process to occur.  
 
3.3 ASCs encapsulation on the different hydrogels 
 
After the trypsinization of the ASCs, the cell number and viability were determined with a Neubauer 
chamber, using the trypan blue exclusion test. The cellular suspension was centrifuged as 1200rpm, at 
4ºC for 5 min and the supernatant was aspirated completely to obtain a pellet, which was mixed with the 
different hydrogels.  
3.3.1 Gellan-Gum 
After obtaining the GG-GRGDS (50:50 proportion) and adding the CaCl2, the hydrogel was then thoroughly 
mixed with the cells pellet until it was obtained and homogeneous solution. The addition of CaCl2 before 
the encapsulation of the cells avoids their damage by the aggressive reaction. The cells are encapsulated 
on the GG at a concentration of 6x105 cells/ml, by mixing the gel solution with the cells’ pellet and 
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homogenising to equally distribute the cells along the gel. The hydrogel containing the cells was put on a 
Lab-Tek chambered coverglass/24 well plate in drops of 50μl per chamber/well. The cultures were 
maintain for 4 days and 7 days in N-M (DRGs) or Ϊ-MEM (ASCs). 
3.3.2 NVR-Gel 
After mixing the hydrogel with the culture medium it was obtained a liquid viscous gel. This viscous 
solution was added to the cells’ pellet and mixed to uniformly distribute the cells. Then 250μl of the gel 
containing the ASCs, at a concentration of 6x105 cells/ml, was added to each well of the 24 well plate 
and were also cultured for 4 and 7 days in N-M (DRGs) or Ϊ-MEM (ASCs).  
3.3.3 Collagen  
In the collagen gels, once the mixture was homogenous, the ASCs were mixed with the hydrogel at a 
concentration of 6x105 cells/ml and made uniform by successive up and down movements. The gel 
containing the cells was platted on the wells/coverglass chamber in 50 μl drops and left in the incubator 
for 1,5h at 37 °C and 5% CO2 for the gelification process to occur. After 1,5h the culture medium was 
added, using N-M for DRGs or Ϊ-MEM for ASCs. 
 
3.4 MTS test  
 
The MTS assay is a test that relies on the reduction of the tetrazolium compound 3-(4,5-dimethylthiazol-
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS, Promega) to formazan by viable 
cells. This reduction is only possible when reductase enzymes are active, which allows to do a direct 
conversion of the secreted formazan with the cells’ viability in culture.  
Formazan is soluble in culture medium and its concentration can be indirectly measured through 
spectrophotometry. After 7 days of culture the medium was replaced by serum-free medium (DMEM) 
containing MTS in a 5:1 ratio and incubated for 3 hours at 37 ºC and 5% CO2. Once completed the 3h of 
incubation, the optic density for triplicates of each sample (n=3) was measured at 490 nm in a microplate 
reader. 
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3.5 Quantitative Real-Time RT-PCR 
 
 Reverse transcriptase-polymerase chain reaction (RT-PCR) is used to amplify complementary 
DNA (cDNA) copies of RNA using a reverse transcriptase. Through the use of sequence-specific primers, 
it is possible to determine the number of copies of a particular RNA sequence, and the quantification is 
made by measuring the amount of amplified product at each stage during the PCR cycle. The detection 
of the PCR products is possible using fluorescence molecules that translate an increase in the amount of 
DNA, with proportional increase in the florescent signal. In the present study, the ASCs were encapsulated 
on the different hydrogel (6x105 cells/ml) and this test was used to analyze the expression levels of 
specific genes involved in axonal growth.  
 
3.5.1 RNA extraction 
 The total RNA from the ASCs, seeded on the different matrices, was extracted using the Trizol 
solution (Life Technologies). Initially, 1 mL of Trizol were added to the cells followed by a mechanical 
dissociation to homogenize the samples, after which the samples were collected in eppendorfs tubes and 
stored at -20°C. After thawing, the samples were incubated for 3 min at RT with 200 μL of chloroform 
followed by a centrifugation (8000 rpm, 15 min, 4°C). Then, is visible the presence of three layers: an 
aqueous phase on top, an interphase, and in the bottom an organic phase. The aqueous phase, that 
contained the RNA, was removed into a new eppendorf tube, the RNA was precipitated by adding 500 μL of isopropanol, and was left to rest for 10 min at room temperature. Afterwards, the samples were 
centrifuged (9000 rpm, 15 min, 4°C), the RNA pellets were washed with 75% ethanol and centrifuged 
again (5000 rpm, 5 min, 4°C).  Then, the pellets were dissolved in Nuclease-free water and the 
quantification was performed using Nanodrop ND-1000 spectrophotometer (Alfagene, Portugal). The 
samples concentration was adjusted to 500ng/µl  
 
3.5.2 cDNA transformation and quantitative Real-time PCR 
The synthesis of the cDNA was performed using iScriptTM cDNA Synthesis Kit (BioRad, USA). 
Firstly, 1μg of purified RNA was used as template and the volumes were normalized with nuclease-free 
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water. The complete reaction mix (RNA sample, 5x iScript reaction mix and iScript reverse transcriptase), 
demonstrated on Table 1, was left incubating for 5 min at 25°C, followed by 30 min at 42°C and for 
final 5 min at 85°C, in a thermal cycler (Applied Biosystems, USA).  
 
Table 1 - Composition of the cDNA mix. 
 
Components Volume per Reaction 
5x iScript reaction mix 4 μL 
iScript reverse transcriptase 1 μL 
Nuclease-free water x μL 
RNA sample x μL 
Total volume 20 μL 
 
 
In order to perform the quantitative gene expression analysis, the cDNA was subject to PCR 
amplification using Eva Green technology (Ssofast Evagreen supermix, BioRad) on the CFX96 Real-Time 
system (BioRad), to obtain the real-time detection of PCR products.  The reaction solution was obtained 
using 5 μL of Ssofas Evagreen supermix, to which it was added 10 μM from each primer, forward and 
reverse (Table 2) and 1 μL of cDNA was used as template. The cycling conditions applying in this 
procedure were 30 s at 95°C for the enzyme activation, followed by 40 cycles of 5 s at 95°C for 
denaturation, 5 s at 60°C for annealing and 5 s at 72°C for extension step (Table 3). The gene HMBS 
was used as reference, and the genes that were tested were the BDNF, VEGF, NGF and GDNF. 
 
 
Table 2 - PCR primers used to detect gene expression in ASCs, upon seeding in the three hydrogels. 
 
Gene Primer sequence 
HMBS Forward 5’- CCTGGCCCACAGCATACAT - 3’ 
Reverse 5’- TCGGGGAAACCTCAACACC - 3’ 
GDNF Forward 5’- AGCCGCTGCAGTACCTAAAA – 3’ 
Reverse 5’ – CCAACCCAGAGAATTCCAGA – 3’ 
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VEGF Forward 5’- TTTCTTGCGCTTTCGTTTTT - 3’ 
Reverse 5’- AGGCCAGCACATAGGAGAGA - 3’ 
NGF Forward 5’- GTCTGTGGCGGTGGTCTTAT - 3’ 
Reverse 5’- CAACAGGACTCACAGGAGCA - 3’ 
BDNF Forward 5’- AGAAGAGGAGGCTCCAAAGG - 3’ 
Reverse 5’- TGGCTGACACTTTCGAACAC - 3’ 
 
 
3.6 DRG explants isolation and encapsulation on the hydrogels 
 
Dorsal Root Ganglia (DRG) are structures located near the SC and are composed mainly by sensory 
neurons’ cell bodies. DRG explant cultures can be used as an in vitro model for axonal regeneration 
because after being isolated and plated under the appropriate culture conditions, they are capable of 
producing extensive neurite outgrowth. In this sense, DRG explant cultures were performed to evaluate 
the effect of the different approaches, namely the hydrogels, the ASCs and NPs, on neurite outgrowth. 
Firstly Wistar-Han rats with 5-6 days were sacrificed, the DRG were extracted from the thoracic region 
and maintained in cold Hank’s Balanced Salt Solution (HBSS) (1x) without Ca2+ and Mg2+, under sterile 
conditions. The DRG were then cleaned to remove any remaining nerves, blood or meningeal debris 
attached to the structure and placed on top of the GG, the collagen and NVR hydrogels (with or without 
cells). The cultures were maintained for 7 days in N-M and medium was changed each 3/4 days. 
 
3.7 Addition of GDNF-NPs and soluble GDNF to the cultures 
 
Upon finalization of the cultures, it was proceeded to the addition of the GDNF-NPs and soluble GDNF to 
the DRGs cultures. After preparing the hydrogel, both forms of GDNF were previously mixed with N-M (at 
a concentration of 10µg/ml), which was then added to the cultures. Regarding the ASCs cultures, the 
NPs were previously mixed with Ϊ-MEM that was then added to the cells culture.  
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3.8 Immunocytochemistry and Phalloidin/DAPI staining 
 
The immunostaining of the samples was initialized after 4 and the 7 days of culture, respectively. The 
anti-bodies were used to mark neurofilament (NF), which are intermediate filaments found in neurons; 
Phalloidin (Sigma, USA) was used to stain the F-actin filaments within the cells cytoskeleton and DAPI 
(Invitrogen, USA) to mark the cells’ nucleus. The primary anti-body was the mouse monoclonal anti-
human neurofilament 200 kDa (Millipore, USA) and the secondary anti-body was the Alexa fluor 488 goat 
anti-mouse IgG (H+L) (Invitrogen, USA).  
For the immunostaining of the neurofilaments, firstly the wells were washed 3x with PBS (1x) and then, 
the cultures were fixated by adding PBS solution containing 4% paraformaldehyde (PFA), which was left 
for 45 min at room temperature. The chambers were washed 3x with PBS (1x) to remove any remaining 
PFA and it was added 0,3% Triton X-100 (Sigma, USA), for 10 min at room temperature, to permeabilize 
the cell membrane. The samples were washed again with PBS (1x) and blocked with a blocking buffer – 
PBS with 10% FBS (Fetal Bovine Serum) for 1,5h at room temperature. Then, the samples were washed 
with FBS (0,5%) and left incubating with the primary anti-body (previously diluted in PBS 10%) for 48h at 
4 oC. After washing 3x with FBS (0,5%), the remaining procedure was performed with a low light exposure 
due to the addition of the secondary anti-body (previously diluted in PBS 10%) that was left to incubate 
for 24h at 4 oC.  After washing again 3 times with PBS, the sample were ready for microscope visualization.  
Lastly, for the conditions containing the ASCs, a PBS (1x) solution that was previously mixed with 
Phalloidin (1:500) and DAPI (1:100) was added to the wells and left to rest for 45 min at room 
temperature. The samples were cleaned 3x with FBS (0,5%) and it was proceeded to the microscope for 
further analysis.  
 
3.9 Quantification using Image J program 
 
Firstly the micrographs of the cultures were obtained through fluorescence (Olympus BX-61 Fluorescence 
Microscope (OLYMPUS, GERMANY)) and confocal microscopy. The cell survival was quantified by 
counting the number of living cells in six regions taken at random for each gel sample, using the Cell 
counter of the Image J program. For the analysis of the area occupied by the neurites, it was taken two 
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representative micrographs of each sample, which was later quantified the program Image J. The 
program changes the images into 8 bits image, and processes them into a binary image, which will 
convert the green fluorescence (neurofilament staining) into a black image with a white background. The 
body of the DRG was excluded before the quantification that was made using the program’s setting 
“analyse particles”, which automatically calculates the area occupied by the black particles, using as 
contrast the white background.  
 
3.10 Statistical analysis  
 
All statistical analyses were performed using GraphPad Prism version 5.00 for Windows (GraphPad 
Software, USA). Differences among groups were assessed using t-test or one way ANOVA test, followed 
by a Tukey pos-hoc. A p-value of ≤ 0.05 (95% confidence level) was set as the criteria for statistical 
significance (*). 
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4.1 Hydrogels effect on axonal growth 
 
One of the hallmarks of SCI is a fluid filled cavity surrounded by a glial scar, known to chemically 
and physical hamper the growth and reconnection of axons across the lesion site.  One strategy to 
overcome this problem is the use of hydrogels, as they can behave as a milieu to support axonal 
regeneration by promoting axonal attachment and growth, improving the changes of neuronal 
reconnection. Moreover, the soft tissue consistency and porous structure of the hydrogels facilitates the 
incorporation and integration on the lesion site, while allowing the diffusion of molecules[9]. The 
hydrogels’ 3D microenvironment provides a better environment for cells’ distribution/organization and 
their cell-cell and cell-ECM interactions, closer to one found in the native tissues[75]. In the present work 
DRGs explants were used as an in vitro model to test the hydrogels capacity to promote axonal growth. 
After the isolation, DRGs were placed on top of each hydrogel and cultured for 7 days in N-M (serum 
free). The immunostaining for neurofilament allowed the quantification of the area occupied by the DRGs’ 
newborn neurites using the Image J program, as previously described in chapter 3.  
In Figure 4, micrographs a) to c) demonstrate that the three substrates were able to successfully 
promote neuritogenesis. However each hydrogel promoted varying degrees of response on the DRGs 
explants. As seen in Figure 5, the collagen hydrogel induced a significantly higher neurite outgrowth 
(mean=813.013 µm2) than the GG-GRGDS, which in turn promoted the lowest neurite outgrowth 
(mean=197.950 µm2) of the three hydrogels. Lastly, the NVR-Gel presented an increase (mean= 577.727 
µm2) in comparison with the GG-GRGDS but did not reach the axonal growth stimulated by the collagen, 
which was the most permissive hydrogel.  
 
  
Figure 4 - Representative images of the neuritogenesis promoted by the three matrices: a) GG, b) NVR-Gel and c) 
Collagen, when cultured in N-M (supplemented with B27 (2%), L-glutamine (1%), Glucose 30% (2%)). Scale bar: 
200µm. 
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These results can be attributed to the different composition of the three hydrogels, since the DRGs’ 
neurite extension varies depending on the physical properties of the gel (stiffness and pore size), ligand 
concentrations (ECM peptides) and matrix geometry[75]. In living tissues most cells require adhesion to 
the ECM in order to survive and proliferate, and cells display cell-type preferences on binding molecules, 
to ensure the cells are in the correct environment within the organism. Indeed, studies demonstrate that 
ECM components might regulate apoptosis and promote neurite extension on 3D matrices[76]. Cell-ECM 
binding induces a mechanical stimuli from the ECM to the cells’ cytoskeleton, activating intracellular 
signalling molecules that regulate the activity of enzymes (e.g. proteases, kinases, phosphatases) and 
can lead to the modification the cells’ architecture and machinery[75]. For example, collagen is a major 
component of the ECM and recent studies proved it importance in cell-cell and cell-matrix signalling, cell 
adhesion, wound repair and in tissue function[77]. Since then, collagen hydrogels have been widely used 
for neural cultures due to its aptitude to promote cellular attachment and growth, by providing a 
conductive and permissive matrix. Allodi and coworkers performed cultures of DRGs and SC slices 
embedded in collagen 3D hydrogels and cultured in neurobasal enriched medium without serum or 
general trophic factors. They showed that the 3D scaffold allowed motor neurons migration from the SC 
slices and sensory neurons from the DRGs to extend their neurites after 2 and 4 days of culture, [39]. 
This is in accordance with our results, also in serum-free medium, where the collagen demonstrated to 
be permissive for the neurite outgrowth and showed to be supportive for longer periods of culture (7 
days). One in vitro study used embryonic cortical neurons cultures entrapped in collagen hydrogel, and 
compared with an agarose hydrogel to understand the neurons’ interactions with ECM equivalents. The 
study was extended until 24 days. Results showed that the neurons in the collagen gel survived throughout 
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Figure 5 - Quantification of the axonal growth promoted by the three matrices. The mean area occupied by 
neurites was calculated using Neurite J plugin for ImageJ (NIH) software. Results presented as mean ± SD; 
n=4; p< 0.05. 
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the 24 days of culture, while the neurons in agarose only survived 14 days. In addition, the neurons on 
the collagen matrix displayed normal polarity and had developed long neurites, suggesting that collagen 
is a conductive matrix for neuronal survival and elongation[76]. 
Regarding the results obtained for the NVR-Gel, the second higher axonal outgrowth can be related 
with the laminin present in its composition. Laminin is a known adhesion protein present in the ECM and 
has an important role in axon regeneration in vivo[78]. One study cultured dissociated DRG neurons on 
poly-D-lysine surfaces, coated with a thin film of laminin, to examine if the subtract was permissive enough 
to promote neurite outgrowth in the absence of serum or trophic support. The results demonstrated that 
the poly-D-lysine surface containing laminin had a significantly higher growth of neurites than the cells 
plated on regular poly-D-lysine, and that those differences were directly related to the biological effects of 
the laminin[79]. Indeed, Shahar and colleagues cultured DRG slices on NVR-Gel for one week, and 
showed that this hydrogel was able to support the cell maturation and nerve fiber outgrowth of the DRG 
slices. However, in this study the NVR-Gel cultures were performed using medium supplemented with 
neurotrophic factors (GDNF, NGF or FGF) and serum, which could explain the enhanced improvement in 
comparison with the present results. The fact that the NVR-Gel used in the present study did not contained 
any growth factors or serum, but still manage to promote the second higher neurite extension, indicates 
that it is also a suitable matrix for axonal growth, when compared to collagen hydrogels[46]. 
Even though the GG-GRGDS promoted the lowest area of neurite outgrowth of the three matrices, 
the survival and extension of the DRGs neurites was accomplished. This effect is correlated with the 
presence of the fibronectin peptide (GRGDS) in the GG structure, which is a cell-adhesive peptide shown 
to enhance cell-biomaterial interactions and to support the cells’ survival. Silva et al. cultured neural 
stem/progenitor cells (NSPCs) on both peptide-modified GG-GRGDS and unmodified GG to assess the 
importance of this peptide sequence for cell-hydrogel interaction. Indeed, the results showed that the GG-
GRGDS profoundly enhanced the NSPCs survival, morphology and proliferation when compared with the 
unmodified GG, confirming that this functionalization induces a more adhesive and permissive substrate 
for cell growth[27]. Another study produced a 3D brain-like structure, using bioprinting techniques, 
consisting of layers of primary cortical cells encapsulated on both regular GG and RGD-modified GG. This 
study also confirmed that RGD-modified GG supported and enhanced the cell adhesion, differentiation 
and network formation compared to unmodified GG, demonstrating that the cortical neurons responded 
better when the peptide is present[80]. All hydrogels supported axonal survival and growth, which 
confirms the importance of ECM molecules for an efficient cell-matrix interaction when developing a 
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scaffold, but the collagen demonstrated to be a more permissive and conductive matrix for axonal 
migration.  
 
 
4.2 Hydrogels influence on the ASCs survival,proliferation and gene 
expression 
 
Recent discoveries of the MSCs’ immunomodulatory capacity with pro-survival character and 
regenerative potential proven to be related with their secretome, which lead researchers to increasingly 
studying them for numerous pathologies[81]. As previously stated, MSCs transplantation is a promising 
therapy to tackle the complex and diversified events that occur in SCI. Additionally, the capacity of self-
renewal with low senesce throughout passages and the easy isolation and expansion, without any 
technical or ethical concerns, increases the changes of clinical applications[15]. However, these cells 
have difficulty in surviving the harsh microenvironment created at the lesion site and therefore, the 
engraftment rate of transplanted cells is lower than the required to induce a regenerative response[58]. 
For that reason, hydrogels have been proposed as a substrate that promotes the cell survival and 
proliferation besides being able to locally sustaining them, allowing a constant secretion of molecules and 
dodging the need of repeated administrations[9].  
 
4.2.1 ASCs survival and metabolic activity in the three matrices 
 
The second task of this work was to assess whether the GG-GRGDS, NVR-Gel and Collagen had the 
capacity to promote the ASCs survival, viability and proliferation, while exhibiting their typical spindle-like 
morphology. In this task, the ASCs were encapsulated on the three hydrogels (6x105 cells/ml) and 
cultured for 7 days in α-MEM (containing serum), using 2D cultures as the control group. After the 7 days 
of culture, the DAPI/Phalloidin staining was made and the qualitative and quantitative analysis were 
performed. 
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The micrographs a) to d), of Figure 6, demonstrated that all hydrogels were supportive to the ASCs’ 
survival and proliferation, while promoting the cells’ typical morphology. However, the cells had different 
degrees of response upon seeding in the different matrices, with the quantitative analysis showing 
significant differences between all the hydrogels and with the control (Graphic a) in Figure 6). The highest 
cell density was obtained in the NVR-Gel (mean=377,6), with statistical differences from the GG-GRGDS 
and collagen, besides being statistically higher than the control (mean=300,2). The second higher cell 
density was stimulated by the collagen (mean=188,05), being the lowest cell density observed on the 
GG-GRGDS (mean=26,85), both presenting statistical differences between them, the NVR-Gel and the 
control. The discrepancies on the results highlight the role of the ECM on the adhesion, survival and 
proliferation of cells, besides demonstrating the cell-type affinity to different ECM molecules. 
 
 
For example, the highest number of cells obtained on the NVR-Gel is an effect caused by the 
presence of laminin, which is an adhesion molecule, but also triggered by the HA present in the hydrogel’s 
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Figure 6 - Representative images of the ASCs morphology when cultured in the three matrices: a) ASCs 2D cultures, b) ASCs on 
GG and c) ASCs on NVR-Gel, d) ASCs on Collagen. Graphs demonstrating the ASCs’ density and the ratio cell density/metabolic 
activity, when cultured in the three hydrogels in Ϊ-MEM. Quantification was made using ImageJ (NIH) software. Results presented 
as mean ± SD; n=4; p< 0.05. Scale bar: 200µm. 
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composition. In the bone marrow stroma, HA is the major glycosaminoglycan component of the ECM, 
having a role in cell positing, proliferation, migration and differentiation, and its main cell surface receptor 
is the CD44[82]. Interestingly, CD44 besides being involved in cell-matrix interactions and cell 
migration[83], is a surface receptor documented to be present in MSCs[84]. For instance, Zhu et al. 
evaluated the CD44-HA interaction in rat MSCs migration, and the effect of stimulating the cells with 
Platelet Derived Growth Factor (PDGF). They discovered that upon PDGF stimulation the MSCs elevated 
their CD44 expression, and that their adhesion and migration was in fact dependent of that interaction, 
since it could be blocked by either CD44 antibody or small interfering RNA[83]. Indeed, the higher cell 
density on the NVR-Gel can be explained by the combined effect of both laminin and HA present in its 
composition, demonstrating that this hydrogel is an appropriated candidate for MSCs transplantation. 
Another ECM molecule known to be involved in cell-cell and cell-ECM signalling and adhesion is the 
collagen. Among the different types of collagens, collagen type-I is found in numerous tissues such as 
bone and adipose tissue[85], and in the bone marrow stroma provides contact points for the MSC to 
attach. Moreover, long term bone marrow cultures and gene expression profiling revealed that BM-MSCs 
themselves are able to produce collagens and laminins, indicating a recognition and preference of those 
proteins by the MSCs[86]. Thus, cells require and recognize ECM molecules that are native/familiar to 
them in order to initiate cell attachment, survival and proliferation. This could explain the second highest 
cell density, stimulated by the collagen hydrogels (collagen type-I), since the cells’ seeding in the collagen 
hydrogel resulted in integrin recognition, and consequent anchorage of the ASCs to the substrate, 
enabling their survival and proliferation. This is in accordance with a report that screened several proteins 
to uncover which molecules allowed a preferential binding of MSCs and the ones that avoided a strong 
adherence of fibroblasts. The results showed that MSCs bind with a higher efficiency to collagens (-I, -III, 
and –IV) and laminin-111 than the fibroblasts, and both cell types bind with equally high efficiency to 
fibronectin[87]. As the latter was demonstrated to induce an efficient binding of the MSCs, the presence 
of the fibronectin peptide on the GG could justify the adherence, survival and typical morphology of the 
ASCs on this matrix. The lowest response on this hydrogel might be owed to the peptide concentration 
on the hydrogel, which may perhaps be lower than the necessary to attain the effect of the remaining 
hydrogels.  Fibronectin is a component of the ECM of many tissues, has a role in cell adhesion, migration, 
growth and differentiation, and regulates a variety of cell activities, mainly through direct interaction with 
cell surface integrin receptors[88]. Moreover, studies point out that arginine-glycine-asparagine-serine (or 
RGDS) sequence is essential for the binding of fibronectin to the transmembrane integrin receptor[89] 
and that this glycoprotein has the ability to bind up to 20 distinct integrins, explaining its influence on 
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multiple cell types[88]. For example Silva et al. encapsulated BM-MSCs within a GRGDS modified GG and 
compared the cells proliferation and metabolic activity with the BM-MSCs seeded on unmodified GG. They 
revealed that the GG-GRGDS originated a higher cell proliferation and metabolic activity than the 
unmodified hydrogel, and that the cell typical morphology was only observed on the GG-GRGDS. Moreover, 
the cell secretome was also positively influenced by the presence of the peptide, as MSCs seeded on GG-
GRGDS induced a higher metabolic viability and neuronal density of primary cultures of hippocampal 
neurons, than the MSCs on regular GG[50]. Taking this into account, it was performed a metabolic activity 
test (MTS assay), that relies on the capability of cells to metabolize the tetrazolium compound into a 
formazan salt, allowing the measurement of the cells metabolic activity. Interestingly, the ratio cell 
density/metabolic activity (Graphic b) in Figure 6) revealed that even though the GG-GRGDS had the 
lowest cell density, the cells that survived presented a significant increase in their metabolic activity, when 
compared with the remaining hydrogels and the control. This is similar to the results obtained in the 
mentioned study by Silva et al., as this peptide had a positive effect on the cell survival and morphology, 
besides influencing the cells intrinsic machinery[50]. The metabolic activity of the ASCs seeded in NVR-
Gel was similar to the control, and the ASCs in collagen were slightly lower than the control, suggesting 
that those hydrogels effects on the cells metabolic activity was not pronounced or diminished. In 
conclusion, all substrates promoted the ASCs survival and proliferation, showing varying responses such 
as the higher density and migration of the ASCs promoted by the NVR-Gel, or the GG that induce a more 
profound effect on the cells’ metabolic activity. These results demonstrated the powerful control ECM 
molecules exert on cellular functions and how ECM-incorporation on scaffolds provides a higher response, 
being advantageous for tissue engineering approaches.   
 
  
4.2.2 ASCs’ gene expression on the three hydrogels 
The previous tasks demonstrated that the hydrogels had different influences on the ASCs’ viability 
and metabolic activity, which lead to the thought that their gene expression might also have differences, 
promoted by the three hydrogels. For that reason, the cells were encapsulated on the different hydrogels 
(6x105 cells/ml) and their expression of VEGF, BDNF, GDNF and NGF was analysed using quantitative 
real-time PCR. The latter three neurotrophic factors belong to the neurotrophin family, which has an 
important role in neuronal survival and/or protection and axonal growth[90]. For example, the BDNF 
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supports motor and sensory neuron survival (neuroprotective effects) besides promoting the regeneration 
of axons in sensory and motor neurons[91]; the GDNF also enhances the survival and outgrowth of both 
motor and sensory neurons[46] in addition to stimulating axon sparing and regeneration[92]; and the 
NGF was proven to be neuroprotective and to promote the survival and neurite outgrowth of sensory and 
sympathetic neurons in vitro and in vivo[62]. The VEGF is a factor known to promote angiogenesis but 
recent proofs indicate that this protein also has a neurotrophic and neuroprotective effect besides 
stimulating axonal outgrowth[93].  
 
 
 
 
 
Interestingly, the preliminary data (Figure 7) demonstrates that the three hydrogels influenced 
the ASCs’ gene expression of the referred growth factors, and that within each hydrogel the quantity of 
expressed factors also varies. Regarding the BDNF and VEGF, the higher gene expression was obtained 
on the collagen hydrogels, while in the GG and NVR-Gel the VEGF expression was equivalent, and the 
BDNF expression in the NVR-Gel was slightly increased. The NGF expression was slightly increased in the 
Figure 7- Changes in the ASCs’ BDNF, VEGF, NGF and GDNF expression, at the mRNA level, promoted by the 
Collagen, the NVR-Gel and the GG. Results obtained through quantitative real time presented as mean ± SD; 
n=3; p< 0.05.  
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NVR-Gel, being followed by the quantity obtained in the GG and the lower expression was observed on 
the collagen hydrogels. The expression of GDNF was similar in the NVR-Gel and the GG, being observed 
a lower expression on the collagen matrix. These preliminary results strongly suggest that a modulation 
of the secretome is being produced by the different hydrogels and that the ASCs adapt their behaviour 
(metabolic activity and gene expression) according to the surrounding environment and the presented 
biological cues. Nevertheless, this was a gene expression analysis that cannot be directly assumed to the 
protein presence, so further studies with protein analysis should be performed to confirm these results. 
Additionally, in this test a low number of replicas was used, so for further work this number should also 
be increased.  
 
 
4.3 The regenerative ability of the ASCs combined with the hydrogels, on 
axonal growth 
In recent years, tissue engineering approaches have arisen for SCI repair, combining hydrogels 
and MSCs for a more efficient scaffold to support both transplanted cells and host cells. The implantation 
of hydrogels on the lesion site assists the cavity bridging, by supporting axonal growth across the scarring, 
and improves the MSCs viability upon transplantation, whose paracrine actions are known to reduce cell 
death and inhibit immune and inflammatory responses, by positively influencing the lesion’s 
microenvironment[94].  
 
4.3.1 ASCs morphology in serum free conditions 
 
Having the intention of co-culturing the ASCs with the DRG explants in the next task, the ASCs 
cultures had to be performed using the suitable medium for the DRGs cultures, the Neuron-Medium, 
which does not contain serum. For that reason, before starting the co-cultures it was assessed whether 
the hydrogels still promoted the ASCs survival, viability and typical morphology, without serum 
supplementation. The cells need to exhibit their normal morphology because the display of a round shape 
is a characteristic of non-viable cells. Moreover, it is also hypothesized that any alteration in the cells 
 44 
 
structure might affect the cells machinery, altering the secretion of factors and their regenerative 
capacity[50].  
In this task the ASCs were seeded in the different hydrogels (6x105 cells/ml), cultured for 7 days 
in Neuron-medium and the following DAPI/Phalloidin staining allowed the visualization of the cells’ 
morphology. Figure 8 shows that the GG-GRGDS (a) and collagen (c) continued to preserve the ASCs 
spindle like shape, with apparently higher cell density on the collagen than the GG-GRGDS, suggesting to 
be a more supportive substrate. Nevertheless, both hydrogels were able to support the cells adhesion 
and viability, even under serum-deprived conditions. On the other hand, when seeded on NVR-Gel (b) 
most of the ASCs displayed a more spheroid form with only some cells presenting their normal shape, 
indicating that this hydrogel needs optimization through extra supplementation to give full support to the 
cells.   
 
 
4.3.2 NVR-Gel optimization 
 
For the optimization of the NVR-Gel it was tested the supplementation of neurobasal medium 
with low doses of serum, 0,1%, 0,5% and 1% of FBS, to assess the minimum concentration needed to 
support the ASCs survival for 4 days of culture, avoiding high doses of serum in order to have minimal 
interference with the DRGs explants.  
Among the three concentrations of FBS, the 0,1% FBS somewhat improved the ASCs morphology 
comparing with the normal N-M, but was still insufficient in fully supporting the ASCs since several cells 
with the spheroid form were still observed (micrographs b) to d) in Figure 9). Regarding the other two 
concentrations (0,5% and 1% FBS), both stimulated the ASCs survival and spindle-like shape, providing a 
Figure 8 - Representative images of the ASCs morphology when cultured in the three matrixes in serum free conditions: a) 
ASCs on GG and b) ASCs on NVR-Gel, c) ASCs on collagen. Scale bar: 200µm. 
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similar response of the ASCs. The cell count confirmed that the latter two concentrations induced the 
survival of almost twice the cells than the N-M with 0,1% of FBS, but between the 0,5% and the 1% there 
were no statistical differences (Graphic in Figure 8). Having the intention of using the lowest possible 
concentration of FBS, and as between the 0,5% and 1% FBS no morphological or statistical differences 
were found, the N-M with 0,5% of FBS was the concentration chosen for the NVR-Gel optimization. After 
NVR-Gel optimization, the next task was to assess the regenerative potential of the ASCs combined with 
the three hydrogels, using DRGs explants as model for axonal growth.   
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Figure 9 - Representative images of the ASCs morphology when cultured on NVR-Gel, using different concentrations 
of FBS: a) regular N-M, b) N-M with 0,1% FBS  c) N-M with 0,5% FBS  d) N-M with 1% FBS. Graphic demonstrating 
the cells’ density on the three concentrations of FBS. Quantification was made using ImageJ (NIH) software. Results 
presented as mean ± SD; n=4; p< 0.05. Scale bar: 200µm. 
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4.3.3 Axonal growth stimulated by the ASCs addition to the three hydrogels 
 
The previous tasks established that both DRGs and ASCs monocultures could survive and 
proliferate on the three matrices, and revealed that the hydrogels had influenced the ASCs’ survival, 
proliferation and morphology as well as the neurite outgrowth. Herein, it was propose the combination of 
ASCs within the GG-GRGDS, Collagen or NVR-Gel, to evaluate the regenerative ability stimulated by the 
ASCs together with these three matrices. DRGs explants were used as models for axonal growth. In this 
task the ASCs were encapsulated on the different hydrogels, the DRGs were placed on top and cultured 
for 7 days in N-M (with or without serum). After 7 days the samples were imunnostained and the 
quantification was made as previously described (Chapter 3). Results are shown in Figures 10, 11 and 
12.  
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Figure 10 - Graphics for the quantification of the axonal growth, promoted by the ASCs addition to each hydrogel. 
The mean area occupied by neurites was calculated using Neurite J plugin for ImageJ (NIH) software. Results 
presented as mean ± SD; n=4; p< 0.05. 
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Firstly, an analysis of each hydrogel co-culture allows the individual assessment of which cell-
matrix combination, of the three hydrogels, was more effective in stimulating axonal regeneration. 
Concerning the NVR-Gel co-cultures, the results showed that the ASCs combination only provoked a mild 
increase in serum free conditions, and no increase or decrease was observed when supplemented with 
0,5% serum (Graphic a) and b), respectively, in Figure 10). This might mean that the cells’ secretome is 
in some way being negatively affected by the NVR-Gel, as even with the gel optimization, which improved 
the cells’ morphology and viability in task 4.3.1, the cells did not stimulated an improvement in the 
neuritogenesis. Further investigation of the ASCs’ secretome upon seeding in the NVR-Gel, such as 
proteomic analysis or quantitative reverse transcriptase-PCR (qRT-PCR), should be performed for 
confirmation. Regarding the collagen co-cultures, the ASCs addition stimulated an enhancement in the 
neurite outgrowth, although with no statistical differences, while the results of the ASCs with the GG-
GRGDS showed that the ASCs induced a statistically higher increase on the axonal growth than the control 
(Graphic d) and c), respectively, in Figure 10). 
In order to compare the ASCs effects between the three hydrogels, it was performed the 
normalization of the data for the control (hydrogel without cells), which was established as the 100%. 
Figure 11 - Representative images of the co-cultures in the three matrices in serum free conditions: a) GG 
control, b) co-cultures on GG, c) NVR control, d) co-cultures on NVR-Gel, e) Collagen control and f) co-cultures 
on Collagen. Scale bar: 200µm. 
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Upon normalization of the data, it is possible to compare the three matrices effect on the ASCs 
regenerative potential (Figure 12). This showed that ASCs on the GG-GRGDS promoted the highest 
increase (970%) on the axonal growth in comparison with the GG-GRGDS without cells, being statistically 
different from the ASCs in collagen (150%), and the ASCs on NVR-Gel that did not reach the 100% (±80%). 
 
 
 
 
The data collected for the GG-GRGDS based hydrogel suggests that this matrix is supportive for 
the ASCs survival, and that the secretome is being positively influenced by it. This goes in accordance 
with the study performed by Silva et al.[50], which tested the impact of the GRGDS-GG versus the regular 
GG, on BM-MSCs behaviour and secretome, assessing the latter using cultures of hippocampal neurons. 
They revealed that the presence of the peptide resulted in a higher proliferation and metabolic activity of 
the BM-MSCs, besides affecting in a positive way their secretome, which induced higher metabolic viability 
and neuronal cell density than the unmodified GG. 
 
Some information should be taken into consideration for the purpose of synergistically using 
hydrogels and ASCs in SCI applications. One fact that should be noticed is that both collagen and NVR-
Gel have a mean control group rounding the 800.000 um2 of area of neurite outgrowth, while the GG-
GRGDS control group only has a mean of around 50.000 um2. This suggest that the collagen and the 
NVR-Gel single effect has a greater contribution to the neurite outgrowth in comparison with the GG-
GRGDS effect, which was also observed on the DRG monocultures (Task 4.1). This should be considered 
because, even though the GG-GRGDS had a more profound effect on the ASCs regenerative potential 
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Figure 12 - Graphic of the quantification of the neurite outgrowth promoted by the ASCs on the three hydrogels, in 
serum free conditions.  The mean area occupied by neurites was calculated using Neurite J plugin for ImageJ (NIH) 
software. Results presented as mean ± SD; n=4; p< 0.05. 
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(improving 9 times), the combined use with this hydrogel only improved the axonal outgrowth to around 
500.000 um2. On the other hand, the combination of ASCs with the collagen enhanced the axonal growth 
to ±1200.000 um2, showing that this combination stimulated two times more axonal growth than the GG-
GRGDS combination.  
 
After examining the effect of the three matrices in single and co- cultures and having the intention 
of using a combination that improves both axonal growth and ASCs viability and paracrine actions, the 
hydrogel that fulfilled all the requirements was the collagen. This hydrogel promoted the highest neurite 
outgrowth of all matrices on the DRGs monocultures; stimulated the second higher cell density of the 
ASCs on normal culture conditions and the VEGF and BDNF gene expression was higher in this 
hydrogel(Task 4.2), which might have some influence in the results; continued to support the cells’ 
survival in serum—free conditions (Task 4.3); the ASCs in this matrix improved 50% the axonal growth; 
and the combined use of this hydrogel with the ASCs scored the highest axonal outgrowth of the three 
matrices in this task; Once established the best cell-matrix combination, the next step is to evaluate the 
effect of the biomolecular strategy on axonal growth.  
 
 
 
4.5 GDNF-NPs effect on axonal growth and length, on collagen hydrogels 
 
Neurotrophic factors are signalling proteins, shown to have a vital and complex role in supporting 
neural survival, growth and differentiation, promoting axonal growth and maintaining the neuronal 
function since embryonic stage, throughout postnatal development and during adulthood. Their use for 
both research and clinical proposes has been increasing since it was discovered the positive effects they 
have on several neural cells, and how they can be used in injury scenarios[95]. Nevertheless, the use of 
free growth factors has the disadvantage of rapid enzymatic degradation and short half-life time in vivo, 
which compromises their biological activity after short periods of time, requiring several administrations 
to maintain its effect. For that reason, using biomaterial as NPs, helps to stabilize and maintain the 
neurotrophic factor’s effect for longer periods of time, avoiding repeated administrations[46].  
In this task it was evaluated the NPs effect on axonal growth and length, and also compare the 
NPs stability on culture with the soluble GDNF, using DRGs for the model of axonal growth. Here, the 
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DRGs were placed on top of the collagen hydrogels and cultured for 7 days in N-M containing the NPs, 
or containing the soluble GDNF (both at a concentration of 10µl/ml) and using regular N-M as the control. 
The use soluble GDNF helps to assess the efficacy of the NPs in promoting the neurotrophic factor stability 
and if the NPs are affecting the GDNF effects.  
 
 
 
 
 
The results (Graphic a) in Figure 13) showed that the area of axonal outgrowth was significantly 
increased on both soluble (mean= 764.248um2) and NPs-conjugated (mean=573.311um2) GDNF, when 
compared with the control (mean= 176.585um2). This confirms the beneficial effects of using GDNF for 
the survival and extension of axonal growth since both GDNF-NPs and soluble GDNF enhanced, 2 and 3 
times respectively, the neuritogenesis regarding the control. No statistically differences were found 
between the GDNF in its soluble form and the NPs-conjugated GDNF, but a slightly higher area of neurites 
was obtained for the soluble GDNF. This might be explained by a quicker and easier accessibility of the 
GDNF on its soluble form, while in the GDNF-NPs the covalent conjugation of the factor to the NPs might 
be provoking a delayed availability.   
Concerning the length of the longest neurite (Graphic b) in Figure 13), the GDNF in both soluble 
(mean=1704um2) and NPs (mean=1816um2) forms produced a longer neurite extension, comparing with 
the control, which confirms that this neurotrophic factor has a strong effect on axonal elongation. Also, 
the GDNF-NPs induced a slightly lower area of neurite outgrowth than the soluble GDNF, but the neurites 
appear to be longer when the NPs are present. Both tests show that the NPs at least produce the same 
effect as the soluble GNDF, so to further confirm the stability of the GDNF-NPs, a prolonged study (e.g. 
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Figure 13 - Graphics for the quantification of the area of neurite outgrowth and the longest neurite length, 
promoted by the GDNF-NPs and the soluble GDNF on collagen. The mean area occupied by neurites was 
calculated using Neurite J plugin for ImageJ (NIH) software. Results presented as mean ± SD; n=4; p< 0.05. 
 51 
 
15-20 days of culture) should be considered. A prolonged study will help to confirm if the NPs prolonged 
the GDNF bioactivity to a time point where the soluble GDNF would most likely be fully degraded, 
indicating a successful stabilization and prolongation of the GDNF bioactivity[96]. This was described by 
one study that evaluated the biological effects of free (soluble form) versus conjugated (NPs)- neurotrophic 
factors (NGF, GDNF and FGF) using SC slices and DRGs cultures of 15 days. They demonstrated that the 
NPs successfully stabilized and prolonged the effect of the neurotrophic factors for longer periods of time, 
showing that at that point the soluble form of the same factors were no longer present or affecting the 
cultures[46]. 
 
 
 
 
 
 
 
 
 
 
 
 
4.6 NPs toxicity evaluation 
 
The last goal of this thesis was to join the ASC in collagen with the NPs, to evaluate the therapeutic 
effect of this synergistic approach for SCI repair. However, before, it was essential to learn if the NPs did 
not have a deleterious effect on the ASCs survival and metabolic activity. For that propose, the ASCs were 
plated at 6x105 cells/ml on a 24-well plate and were cultured for 4 days in Ϊ-MEM containing the NPs, 
at a concentration of 10µg/ml, or in regular Ϊ-MEM that was used as the control. After 4 days in culture, 
the Phalloidin and DAPI staining and the MTS test were performed to evaluate the ASCs densities and 
metabolic activity, respectively. 
a) b) c) 
Figure 14 - Representative images of the neurite outgrowth promoted by the a) DRG control, b) DRG + GDNF-
NPs and the c) DRG + soluble GDNF, on collagen. Scale bar: 200µm. 
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The cell count (Graphic a) in Figure 15) showed that the cell density on the Ϊ-MEM containing 
the NPs had a mild decrease from the control but without significant differences, indicating that the NPs 
do not have a deleterious effect on the ASCs viability.  
 
 
Regarding the cells’ metabolic activity (Graphic b) in Figure 15), the MTS assay demonstrated 
that when the NPs are present, the ASCs display a lower metabolic activity, with significant differences. 
It seems that the NPs are exerting a negative influence on the ASCs metabolic activity, suggesting that 
their intrinsic machinery might be altered. One aspect that should be considered is that the cells’ 
secretome, and therefore their regenerative potential, may also be altered by the presence of the NPs. 
For that reason, in the next task it was tested whether the ASCs beneficial actions on axonal growth were 
being affected by the NPs.  
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Figure 15 - Representative images of the ASCs morphology when cultured on a) normal Ϊ-MEM or b) Ϊ-MEM containing the 
NPs, at a concentration of 10µg/ml. Graphics demonstrating the cells’ a) density and b) metabolic activity in the absence 
or presence of the GDNF- NPs. The quantification was made using the ImageJ (NIH) software. Results presented as mean 
± SD; n=4; p< 0.05. Scale bar: 200µm. 
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4.7 Axonal growth promoted by the combined therapy 
 
Summarizing, the ASCs in collagen hydrogels demonstrated to be the superior interaction for the 
enhancement of axonal growth, and the NPs presence improved the area and length of the DRGs neurites, 
on collagen cultures. On the other hand, when the ASCs are incubated with the NPs, results demonstrate 
that even though the density was not affected, their metabolic activity was significantly decreased, leading 
to the thought that the secretome might also be altered. Having this in mind, the last step is to evaluate 
if the regenerative potential of the ASCs in collagen is being affected by the presence of the NPs, using 
the DRGs as the model of axonal growth. In this task, the ASCs were encapsulated on the collagen, the 
DRGs were placed on top and the NPs were added to the cultures medium (at a concentration of 
10µl/ml). The quantification of the area occupied by the neurite outgrowth (Graphic in Figure 16) 
demonstrated that the NPs alone (mean=718.945um2) promoted a higher area of outgrowth than the 
control (only collagen) (mean=199.323um2), as seen in task 4.5, although in this task no significant 
differences were found. Regarding the combinatorial approach (mean= 971.201um2), this experimental 
group promoted a significant increase in the area of neurite growth in comparison with the control, and 
was also higher than the group of only NPs, although without statistical differences. Interestingly, the 
experimental group of only ASCs promoted the highest neurite outgrowth (mean= 1652397um2), being 
significantly higher than the control, the group containing only NPs and the combinatorial approach.  
 
The fact that the group containing only ASCs promoted the highest axonal growth, and that the 
combinatorial approach was unable to reach axonal growth promoted by the ASCs combined with collagen 
approach, suggests that the NPs addition is decreasing the regenerative effects of the ASCs. Taking into 
consideration the previous task, demonstrating that the cells metabolic activity was decreased when the 
NPs were present, together with the results obtained in this task, it seems that the cells and/or their 
secretome are being negatively affected by the NPs. Further analysis (e.g. proteomic or gene analysis) of 
the cultures should be made to investigate in which way the cells and their secretome are being affected 
by the NPs. From this task it is possible to confirm that ASCs-collagen interaction promotes a significant 
increase in axonal growth, but that this improvement is hampered when the NPs are present, indicating 
that their addition had a more deleterious effect than beneficial.  
Some studies report that the cytocompatibility of nanomaterials is strongly influenced by 
numerous characteristics of the nanomaterials, such as their chemical composition and surface 
topography, which are also important factors for cell and surface interactions. The NPs can influence the 
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behaviour of cells that are in contact with them, by affecting the cells viability, adhesion, proliferation and 
their paracrine actions[97]. For that reason, without further investigation on the inhibitory effect provoked 
by the GNDF-NPs, their combined use with ASCs is not advantageous, at least in applications where the 
cells and the NPs are in direct contact and/or are intended to be applied at the same time.  
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Figure 16 - Representative images of the synergistic approach: a) DRG control, b) DRG + ASCs, c) DRG + GNDF-NPs, d) DRG 
+ ASCs + GDNF-NPS, on collagen hydrogel. Graphic for the quantification of the area of neurite outgrowth promoted by the 
several experimental groups. The mean area occupied by neurites was calculated using Neurite J plugin for ImageJ (NIH) 
software. Results presented as mean ± SD; n=4; p< 0.05. Scale bar: 200µm. 
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Spinal Cord Injury remains a physical, psychological and economic problem, lacking in 
regenerative therapies that translate into a complete and functional recovery of the patients. Numerous 
strategies have been arisen for the treatment of SCI, but single therapy approaches were shown to be 
insufficient in successfully repairing the injured SC. For that reason, combinatorial approaches that act 
in a synergistic arrangement, can help overcome this problem, as one technique enhances or avoids the 
limitations of the individual technique. This work demonstrated that the use of hydrogels aids in the 
support of both axonal growth and ASCs, provides a permissive matrix for the regrowth of new axons and 
enhances the known regenerative potential of the MSCs. The results from this thesis also reveal the 
importance of having biological cues, such as ECM molecules, in order to promote a more effective and 
pronounce effect on both the ASCs and DRGs cultures. Moreover, it appears the cells vary their gene 
expression depending on the biological cues present on the hydrogels and that cells modulate their 
behaviour accordingly. The interaction of the ASCs with the collagen positively affected the ASCs viability, 
morphology and secretome, besides supporting and promoting the highest axonal growth, indicating to 
be a strong strategy for SCI applications.  
Furthermore, the use of neurotrophic support helps with the low endogenous capacity of neurons 
to regenerate and regrow and enhances axon growth and elongation. The present results demonstrated 
an improvement by both GDNF-NPs and soluble form, confirming the positive effects of using neurotrophic 
support. Future work should be made to confirm the advantage of using NPs to prolong the GDNF, and 
also to investigate the observed deleterious effects on the ASCs paracrine actions. This establishes that 
ASCs-collagen interaction is sufficient to significantly improve the axonal growth and that sometimes “less 
is more”, as in this case too many interactions might be occurring that might be influencing the cultures 
in several ways. A deeper understanding of the different interactions might give new insights for tissue 
engineering approaches, and perhaps getting one step closer to a successful and functional recovery 
from SCI. 
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